Analysts Set Globe Life Inc. (NYSE:GL) Price Target at $175.89

Globe Life Inc. (NYSE:GL) has been assigned an average recommendation of “Moderate Buy” from the twelve research firms that are presently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $179.70.

GL has been the topic of a number of analyst reports. Jefferies Financial Group raised their price objective on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a report on Friday. Piper Sandler increased their target price on Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a report on Tuesday, May 26th. Morgan Stanley raised their price target on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. TD Cowen lifted their price target on Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a report on Tuesday, June 23rd. Finally, Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and set a $168.00 price objective on shares of Globe Life in a research report on Thursday, March 26th.

Globe Life Trading Up 0.1%

NYSE GL traded up $0.24 during trading on Friday, hitting $179.10. The stock had a trading volume of 318,111 shares, compared to its average volume of 660,805. The company has a market capitalization of $13.91 billion, a PE ratio of 12.39 and a beta of 0.47. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. The firm has a 50 day moving average price of $163.71 and a 200 day moving average price of $150.19. Globe Life has a twelve month low of $117.30 and a twelve month high of $182.32.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). The business had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the previous year, the business posted $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, equities research analysts forecast that Globe Life will post 15.64 earnings per share for the current year.

Globe Life Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a dividend of $0.33 per share. The ex-dividend date is Monday, July 6th. This represents a $1.32 annualized dividend and a yield of 0.7%. Globe Life’s payout ratio is presently 9.13%.

Insider Transactions at Globe Life

In other Globe Life news, CEO James Matthew Darden sold 4,663 shares of the stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the transaction, the chief executive officer directly owned 58,451 shares in the company, valued at $8,994,439.88. This represents a 7.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Thomas Peter Kalmbach sold 15,637 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $153.65, for a total transaction of $2,402,625.05. Following the sale, the chief financial officer directly owned 45,335 shares in the company, valued at approximately $6,965,722.75. The trade was a 25.65% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 124,187 shares of company stock valued at $19,529,414 over the last three months. 2.11% of the stock is owned by corporate insiders.

Institutional Trading of Globe Life

Institutional investors and hedge funds have recently made changes to their positions in the company. SG Americas Securities LLC grew its position in shares of Globe Life by 909.6% during the fourth quarter. SG Americas Securities LLC now owns 99,746 shares of the company’s stock worth $13,950,000 after acquiring an additional 89,866 shares during the last quarter. Tudor Investment Corp ET AL acquired a new stake in Globe Life during the 3rd quarter worth $7,348,000. JPMorgan Chase & Co. boosted its stake in Globe Life by 11.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 247,947 shares of the company’s stock worth $35,449,000 after purchasing an additional 24,785 shares during the period. Capitolis Liquid Global Markets LLC purchased a new position in Globe Life during the 3rd quarter worth $5,862,000. Finally, Magnetar Financial LLC grew its position in Globe Life by 2,185.8% during the 3rd quarter. Magnetar Financial LLC now owns 40,435 shares of the company’s stock worth $5,781,000 after purchasing an additional 38,666 shares during the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.